Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
Vaccines01:21

Vaccines

53
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
53
Vaccine Production01:23

Vaccine Production

75
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
75

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

mRNA-based MRI contrast agent for precise diagnosis of glioma and pseudoprogression.

Cell biomaterials·2026
Same author

Engineering drug-responsive replication machinery for precise control of self-amplifying RNA.

Nature biomedical engineering·2026
Same author

Programmable mRNA 3'UTR engineering restores MHC-I and overcomes immune evasion in prostate cancer.

Nature biomedical engineering·2026
Same author

Delivering base editors to the lungs.

Nature materials·2026
Same author

Bioprocess Design and Optimization of Extracellular Vesicles Derived from Mesenchymal Stromal Cells.

ACS nano·2026
Same author

mRNA vaccine immunity is enhanced by hepatocyte detargeting and not dependent on dendritic cell expression.

Nature biotechnology·2026

Related Experiment Video

Updated: Apr 12, 2026

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

5.2K

Recent advances in LNP-mRNA vaccines.

Benjamin J Redenti1, Yichen Zhong2, Changyue Yu2

  • 1Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Colloids and Surfaces. B, Biointerfaces
|April 10, 2026
PubMed
Summary
This summary is machine-generated.

Messenger RNA (mRNA) vaccines, utilizing lipid nanoparticles (LNPs), offer a powerful new approach to immunotherapy. These advanced vaccines demonstrate potent immune responses against various diseases, paving the way for next-generation nanomedicines.

Keywords:
BiomaterialsImmunotherapyLipid NanoparticleNucleic Acid DeliveryVaccinemRNA

More Related Videos

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

4.0K
Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing
08:55

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Published on: January 20, 2023

15.2K

Related Experiment Videos

Last Updated: Apr 12, 2026

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

5.2K
Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

4.0K
Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing
08:55

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Published on: January 20, 2023

15.2K

Area of Science:

  • Immunotherapy
  • Nanomedicine
  • Vaccine Development

Background:

  • Messenger RNA (mRNA) vaccines have transformed immunotherapy through modular mRNA engineering and lipid nanoparticle (LNP) delivery systems.
  • LNPs, comprising ionizable lipids, phospholipids, cholesterol, and PEGylated lipids, are crucial for mRNA stabilization and cellular delivery.
  • Innovations in mRNA chemistry, including nucleoside modification and untranslated region optimization, enhance translation and control immune responses.

Purpose of the Study:

  • To highlight the synergistic advances in LNP-mRNA technology for immunotherapy.
  • To showcase the expansion of LNP-mRNA platforms beyond infectious diseases into oncologic applications.
  • To illustrate the potential of programmable immunotherapies through rational integration of biomaterial and mRNA engineering.

Main Methods:

  • Leveraging modular mRNA engineering for vaccine design.
  • Utilizing lipid nanoparticles (LNPs) for mRNA stabilization and delivery.
  • Optimizing mRNA chemistry and structure for improved efficacy and reduced innate immune sensing.

Main Results:

  • LNP-mRNA vaccines have shown success in COVID-19 vaccines.
  • Preclinical and clinical studies indicate potent and durable immune responses against viral, bacterial, and cancer targets.
  • The technology is rapidly expanding across infectious and oncologic diseases.

Conclusions:

  • The rational integration of biomaterial design and mRNA engineering defines a new generation of programmable immunotherapies.
  • Continued refinement of LNP composition and mRNA architecture will broaden the applications of mRNA nanomedicines.
  • LNP-mRNA platforms hold significant promise for both preventive and therapeutic applications.